CorMedix (CRMD) Tops Q1 EPS by 1c

CorMedix (NASDAQ: CRMD) reported Q1 EPS of ($0.25), $0.01 better than the analyst estimate of ($0.26).

For earnings history and earnings-related data on CorMedix (CRMD) click here.

You May Also Be Interested In

• Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
• BridgeBio Oncology Therapeutics, In (BBOT) PT Lowered to $15 at Stifel
• Chewy (CHWY) Reports In-Line Q2 EPS, Offers Guidance